abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
SG&A Expense Growth
-44.21%
Fiscal year · Period ending:
HQL SG&A Expense Growth
Latest reported-44.21%period ending
Latest reported-44.21%period ending
HQL FY SG&A Growth (YoY) (0.00% → -44.21%)
Latest values, visible window
High-resolution chart · PNG
HQL sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -44.2112% | |
| 47.4985% | |
| -16.1198% | |
| 27.5684% | |
| 12.3385% | |
| -85.8765% | |
| -4.8867% | |
| 464.0819% | |
| 52,368,308.2386% | |
| -100% | |
| 30.2045% | |
| 25.9268% | |
| 7.5497% | |
| 198.0798% | |
| 82.5397% | |
| 6.7797% | |
| -13.2353% | |
| -5.5556% | |
| 30.9091% | |
| 7.8431% | |
| -3.7736% | |
| 17.7778% | |
| -4.2553% | |
| 38.2353% | |
| 0% | |
| 21.0526% | |
| 0% | |
| 0% |